XBiotech Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2013 | $-8.9M | $-9.0M | $59.0K | $739.0K |
| FY2014 | $-11.7M | $-13.1M | $1.4M | $7.0M |
| FY2015 | $-33.3M | $-35.6M | $2.3M | $4.4M |
| FY2016 | $-46.0M | $-50.8M | $4.7M | $5.6M |
| FY2017 | $-33.6M | $-35.1M | $1.4M | $1.8M |
| FY2018 | $-16.5M | $-16.7M | $122.0K | $1.7M |
| FY2019 | $-18.3M | $-18.5M | $204.0K | $3.4M |
| FY2020 | $-65.1M | $-68.9M | $3.7M | $12.6M |
| FY2021 | $69.4M | $65.9M | $3.5M | $4.5M |
| FY2022 | $-14.8M | $-15.4M | $585.0K | $5.1M |
| FY2023 | $-18.7M | $-19.1M | $362.0K | $3.3M |
| FY2024 | $-31.0M | $-32.3M | $1.3M | $1.8M |
| FY2025 | $-39.9M | $-40.2M | $289.0K | $3.6M |